Navigation Links
Pink Minis 300V Power Supply from Major Science

ProductsPink Minis 300V Power Supply from Major Science
Company Major Science
Item Pink Minis 300V Power Supply
Price 
Description Major Science Smart Minis 300V power supply (Cat. No. Minis 300VS) is equipped with ever higher voltage, sufficient for SDS-PAGE, and native PAGE applications. Furthermore, the powerful specifications ensure two pairs of terminator pairs can be used simultaneously. The Minis Power Supply is designed for individuals to have his/her own power supply in laboratories to efficiently handle multiple electrophoresis gel tanks reducing the interrupting others experiments and time waiting for the instrument. The Minis power supply only uses a small amount of lab bench space at very reasonable price.
Info Major ScienceMajor Science
No. 7, Hwai-Der Street
Pan-Chiao City, Taipei, Taiwan
Customer Service: 886-2-2256-6980
Fax Number: 886-2-2256-6942
Web Site: http://www.major-sci.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Pink Minis 150V Power Supply from Major Science
2. PowerPlant DNA Isolation Kit from Mo Bio Laboratories, Inc.
3. Total Antioxidant Power Colorimetric Assay Kit from Neogen Corporation
4. EC570-90 Power Supply from Thermo Scientific
5. EC105 Power Supply from Thermo Scientific
6. Mid Range Power Supply from Thermo Scientific
7. PowerPac HV Power Supply With Temperature Probe from Bio-Rad
8. Sequi-Gen GT and PowerPac 3000 Power Supply, 38 x 50 cm, 220-240 V from Bio-Rad
9. Sequi-Gen GT and PowerPac 3000 Power Supply, 38 x 30 cm, 220-240 V from Bio-Rad
10. Wide Mini ReadySub-Cell GT Cell and PowerPac Basic Power Supply from Bio-Rad
11. Sub-Cell Model 192 and PowerPac Basic Power Supply from Bio-Rad
... needs in both the 384-well format and 96-well for... for a variety applications in the field of Drug D...imization) and Research. , Unmatched wash speed ...hing in both 384-well and 96-well plates. The inst...
...Protein Interaction Reagent A powerful new method...on as an in vitro method for protein interaction d... the exclusive Pierce ProFound Sulfo-SBED Biotin L... relating to protein interactions. • The ...
...nd stackable multi-function incubator. It uses a m...en to accurately control temperature and agitation...e temperature in the incubator. Temperature can be...ler. Built in maintenance-free stepping motor for ...
...nd stackable multi-function incubator. It uses a m...en to accurately control temperature and agitation...e temperature in the incubator. Temperature can be...ler. Built in maintenance-free stepping motor for ...
Biology Products:
(Date:11/20/2009)... A decade ago, a group of University of Oklahoma ...some as part of the human genome project. Today,...ontributing to an international effort to sequence...ed by the National Science Foundation for plant ge...e importance, so improving the tomato and crop yie...
(Date:11/20/2009)... , , Toxic dust: Toxins in coal-tar-based seal...inated house dust, according to a USGS study. PAH...molecules found in oil, coal and tar deposits, and... PAHs are often found in house dust; however, the ...mined. Researchers found that dust from indoor are...
(Date:11/20/2009)... Chronic obstructive pulmonary disease (COPD), a ...chitis or emphysema, is the fourth leading cause o...OPD and while researchers have yet to find any rea...arch Institute at The University of Western Ontari...niques to gain new insight into the disease. ,...
Breaking Biology News(10 mins):NSF awards $7.5M grant to University of Oklahoma for plant genomics 2From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Gaining a better picture of lung disease 2Ziosoft Announces Agreement with Imaging 26amp 3B Medical Information Technology to Distribute Ziosoft 26apos 3Bs 3D Advanced Visualization Software 60157 1Ziosoft Announces Agreement with Imaging 26amp 3B Medical Information Technology to Distribute Ziosoft 26apos 3Bs 3D Advanced Visualization Software 60157 2Ziosoft Announces Agreement with Imaging 26amp 3B Medical Information Technology to Distribute Ziosoft 26apos 3Bs 3D Advanced Visualization Software 60157 3Life Extension 28R 29 Introduces Glutathione Cysteine 26amp 3B C Formulation With Setria 28R 29 From Kyowa Hakko USA 60152 1Life Extension 28R 29 Introduces Glutathione Cysteine 26amp 3B C Formulation With Setria 28R 29 From Kyowa Hakko USA 60152 2NYU Poly Launches Unique Undergrad Forum on Invention Innovation and Entrepreneurship 14613 1NYU Poly Launches Unique Undergrad Forum on Invention Innovation and Entrepreneurship 14613 2NYU Poly Launches Unique Undergrad Forum on Invention Innovation and Entrepreneurship 14613 3NYU Poly Launches Unique Undergrad Forum on Invention Innovation and Entrepreneurship 14613 4
...ary medical project aimed at improving the prevent...ase, diabetes and many other serious conditions is...ous planning. , Up to three thousand people living...opportunity to trailblaze the project before it go...ent invitations to take part in the start-up phase...
...ofessor Axel Ullrich, a director at the Max Planck..., already showed at the beginning of the 1990s tha...ows down its growth, and shrinks its tissue. This ...TENT®, whose active ingredient is Sunitinib. SUTEN...nited States, and it is expected to be brought ont...
...ointed exactly how botulinum neurotoxin A - a pote...ost lethal toxins known to man - is able to sneak ...lopment of new treatments against botulism, a para...own as botox. As small amounts of botox are also k...t work could help to quell any risks associated wi...
Other Biology News:Multi-million pound UK Biobank underway 2Multi-million pound UK Biobank underway 3Basic research leads to a novel cancer therapy 2Basic research leads to a novel cancer therapy 3Basic research leads to a novel cancer therapy 4Scientists reveal how deadly toxin hijacks cells 2
(Date:11/20/2009)...tly announced that Dr. Dominique Hebrault will pre...alytical Technology (PAT) in Green Chemistry and G... (PRWEB) November 20, 2009 --...logy (PAT) in Green Chemistry and Green Engineerin...ology (PAT) case studies will be presented on how ...
(Date:11/19/2009)...all/ -- Omeros Corporation (Nasdaq: OMER ) today ...d quarter ended September 30, 2009. For the three ... net loss of $3.9 million, or $1.34 per share, as ...er share, for the same period in 2008. For the nin...orted a net loss of $15.5 million, or $5.29 per sh...
(Date:11/19/2009)...Call/ -- NeoStem, Inc. (NYSE Amex: NBS ), announc...its shareholders, discussing the Company,s acquisi...cals Holdings, Inc. (CHBP), an integrated bio-phar...of China. The merger gives NeoStem a controlling 5..., CHBP,s primary operating subsidiary and a promin...
(Date:11/19/2009)...9 MONITORING FORCE GmbH,announced ...serin in the,indication treatment-relevant levodop...phan drug status designation with the European Med...is a complication of the mainstay,treatment in adv...those,affected, since it may be disabling for the ...
Breaking Biology Technology:Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2